Integrated ReportFiscal Year Ended Mar. 31, 2022

• Corporate Philosophy
• Message from the CEO

Our Company

• Value Creation Model
• Steps toward Becoming a Truly Global Medtech Company
• Overview
• Message from the CFO
• Message from the COO
• Message from the CTO
• Message from the CMSO
• Message from the CAO

Our Strategy

• CxO Roundtable Discussion
• Sustainability
• Key Components of Our Corporate Strategy
• Medical Business Direction
• Endoscopic Solutions Business
• Special Feature: EVIS X1
• Therapeutic Solutions Business
• Special Feature: Urology
• Medical Business Strategy: Chinese Market
• Medical Business Strategy: Strengthening Business Foundations and Corporate Portfolio
• Reprocessing
• Scientific Solutions Business
• Intellectual Property Activities
• Looking Back at Transform Olympus and Onward to the Future
• Evolving Our Corporate Culture

Our Setup

• Directors
• Governance Roundtable Discussion
• Corporate Governance
• Risk Management

Data

• Global Healthcare Data
• 10-Year Financial/Non-financial Data
• Corporate Information/Stock Information

Please see the page below for consolidated financial statements and notes for the fiscal year 2022.

• Consolidated Financial Statements and Notes